Microbix Biosystems Inc. Cash Flow Conversion Efficiency
Microbix Biosystems Inc. cash flow conversion efficiency. Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has a cash flow conversion efficiency ratio of -0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-466.81K ≈ $-337.69K USD) by net assets (CA$24.26 Million ≈ $17.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Microbix Biosystems Inc. (1997–2025)
Cash flow conversion efficiency of Microbix Biosystems Inc. from 1997 to 2025. This chart illustrates how Microbix Biosystems Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View MBX live share price for real-time trading data and today's change.
Microbix Biosystems Inc. Cash Flow Conversion Ratio Explained
Microbix Biosystems Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Microbix Biosystems Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbix Biosystems Inc. ranked by their cash flow conversion efficiency. Also see MBX market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brand Engagement Network Inc
NASDAQ:BNAI
|
-0.512x |
|
Wiseway Group Ltd
AU:WWG
|
0.271x |
|
Cpt Drives & Power Pcl
BK:CPT
|
-0.152x |
|
Imperial Equities Inc.
V:IEI
|
0.026x |
|
Microequities Asset Management Group Ltd
AU:MAM
|
0.066x |
|
Numulae Gestion de Servicios SOCIMI SA
MC:YNUM
|
-0.001x |
|
Pharmx Technologies Ltd
AU:PHX
|
-0.559x |
|
Adicet Bio Inc
NASDAQ:ACET
|
-0.165x |
Annual Cash Flow Conversion Efficiency for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual cash flow conversion efficiency of Microbix Biosystems Inc. from 1997 to 2025. Review how much free cash does Microbix Biosystems Inc. generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$27.79 Million ≈ $20.10 Million |
CA$-80.29K ≈ $-58.08K |
-0.003x | -101.88% |
| 2024-09-30 | CA$28.30 Million ≈ $20.47 Million |
CA$4.35 Million ≈ $3.15 Million |
0.154x | +445.65% |
| 2023-09-30 | CA$24.62 Million ≈ $17.81 Million |
CA$-1.09 Million ≈ $-791.79K |
-0.044x | -131.99% |
| 2022-09-30 | CA$24.94 Million ≈ $18.04 Million |
CA$3.47 Million ≈ $2.51 Million |
0.139x | +22.39% |
| 2021-09-30 | CA$18.56 Million ≈ $13.42 Million |
CA$2.11 Million ≈ $1.52 Million |
0.114x | +8673.40% |
| 2020-09-30 | CA$6.62 Million ≈ $4.79 Million |
CA$8.57K ≈ $6.20K |
0.001x | -69.27% |
| 2019-09-30 | CA$10.54 Million ≈ $7.62 Million |
CA$44.37K ≈ $32.10K |
0.004x | +108.12% |
| 2018-09-30 | CA$10.35 Million ≈ $7.49 Million |
CA$-537.00K ≈ $-388.46K |
-0.052x | -364.96% |
| 2017-09-30 | CA$15.17 Million ≈ $10.98 Million |
CA$297.05K ≈ $214.88K |
0.020x | -67.22% |
| 2016-09-30 | CA$15.29 Million ≈ $11.06 Million |
CA$913.31K ≈ $660.67K |
0.060x | +37.19% |
| 2015-09-30 | CA$13.68 Million ≈ $9.89 Million |
CA$595.40K ≈ $430.70K |
0.044x | +136.59% |
| 2014-09-30 | CA$9.84 Million ≈ $7.12 Million |
CA$-1.17 Million ≈ $-846.97K |
-0.119x | -258.89% |
| 2013-09-30 | CA$5.72 Million ≈ $4.14 Million |
CA$428.36K ≈ $309.87K |
0.075x | +117.64% |
| 2012-09-30 | CA$4.12 Million ≈ $2.98 Million |
CA$-1.75 Million ≈ $-1.27 Million |
-0.425x | -68.21% |
| 2011-09-30 | CA$5.15 Million ≈ $3.72 Million |
CA$-1.30 Million ≈ $-939.78K |
-0.252x | +21.42% |
| 2010-09-30 | CA$5.65 Million ≈ $4.09 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.321x | +5.76% |
| 2009-09-30 | CA$6.41 Million ≈ $4.64 Million |
CA$-2.19 Million ≈ $-1.58 Million |
-0.341x | -32.97% |
| 2008-09-30 | CA$7.62 Million ≈ $5.51 Million |
CA$-1.95 Million ≈ $-1.41 Million |
-0.256x | +67.62% |
| 2007-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.792x | +25.75% |
| 2006-09-30 | CA$1.48 Million ≈ $1.07 Million |
CA$-1.58 Million ≈ $-1.14 Million |
-1.066x | -892.57% |
| 2005-09-30 | CA$2.77 Million ≈ $2.00 Million |
CA$372.31K ≈ $269.32K |
0.135x | -30.91% |
| 2004-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$444.57K ≈ $321.60K |
0.195x | +280.59% |
| 2003-09-30 | CA$1.99 Million ≈ $1.44 Million |
CA$-214.27K ≈ $-155.00K |
-0.108x | -315.02% |
| 2002-09-30 | CA$2.12 Million ≈ $1.53 Million |
CA$106.20K ≈ $76.82K |
0.050x | -70.95% |
| 2001-09-30 | CA$2.05 Million ≈ $1.48 Million |
CA$353.56K ≈ $255.76K |
0.173x | +334.02% |
| 2000-09-30 | CA$1.76 Million ≈ $1.28 Million |
CA$-130.02K ≈ $-94.06K |
-0.074x | +90.36% |
| 1999-09-30 | CA$1.70 Million ≈ $1.23 Million |
CA$-1.30 Million ≈ $-940.40K |
-0.765x | -25.49% |
| 1998-09-30 | CA$6.40 Million ≈ $4.63 Million |
CA$-3.90 Million ≈ $-2.82 Million |
-0.609x | -2337.50% |
| 1997-09-30 | CA$8.00 Million ≈ $5.79 Million |
CA$-200.00K ≈ $-144.68K |
-0.025x | -- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more